High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia

We conducted a retrospective study of 99 patients with methicillin-suseptible Staphylococcus aureus catheter-related bacteremia in which vancomycin MIC was determined by Etest. High vancomycin MIC (>1.5 μg/mL) was the only independent risk factor for development of complicated bacteremia caused b...

Full description

Bibliographic Details
Main Authors:	Aguado, Jose Maria, San-Juan, Rafael, Lalueza, Antonio, Sanz, Francisca, Rodríguez-Otero, Joaquin, Gómez-Gonzalez, Carmen, Chaves, Fernando
Format:	Online
Language:	English
Published:	Centers for Disease Control and Prevention 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358192/

Similar Items

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
by: San-Juan, Rafael, et al.
Published: (2016)

Genetic and Molecular Predictors of High Vancomycin MIC in Staphylococcus aureus Bacteremia Isolates
by: Holmes, N., et al.
Published: (2014)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
by: Panesso, Diana, et al.
Published: (2015)

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia
by: Honda, Hitoshi, et al.
Published: (2011)

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
by: Schweizer, Marin L, et al.
Published: (2011)

Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
by: Wong, Davie, et al.
Published: (2016)

Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia
by: Holmes, N., et al.
Published: (2013)

Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
by: Marguerite L. Monogue, et al.
Published: (2018-09-01)

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages
by: Howe, Robin A., et al.
Published: (2004)

Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia
by: Tsai CY, et al.
Published: (2018-08-01)

The association of molecular typing, vancomycin MIC, and clinical outcome for patients with methicillin-resistant Staphylococcus aureus infections
by: Cheng-Pin Chen, et al.
Published: (2017-10-01)

Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality
by: Hsieh, Yu-Chia, et al.
Published: (2016)

Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia
by: Lachant, Daniel J., et al.
Published: (2013)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
by: Wang, Jiun-Ling, et al.
Published: (2004)

Reduced Susceptibility to Vancomycin in Staphylococcus aureus
by: Mimica, Marcelo J.
Published: (2011)

Evaluating vancomycin susceptibility in Staphylococcus aureus
by: Mimica, Marcelo J, et al.
Published: (2016)

Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates (‘the MIC Creep’): implications for therapy
by: Dhand, Abhay, et al.
Published: (2012)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
by: Eum, Seenae, et al.
Published: (2016)

Combination of Vancomycin and ß-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
by: Davis, J., et al.
Published: (2016)

Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia
by: Seah, Jonathan, et al.
Published: (2013)

Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus.
by: Atsushi Komoto, et al.

Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children
by: Yoo, Ree Nar, et al.
Published: (2017)

Is vancomycin MIC creep a worldwide phenomenon? Assessment of S. aureus vancomycin MIC in a tertiary university hospital
by: Joana, Silvestre, et al.
Published: (2013)

Attributable mortality in critically ill patients with bacteremia involving methicillin susceptible (MSSA) and methicillin resistant Staphylococcus aureus (MRSA)
by: Blot, S, et al.
Published: (2001)

Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
by: Hu, Jian, et al.
Published: (2013)

Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings
by: SPAGNOLO, A.M., et al.
Published: (2014)

Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus
by: Sirichoat, Auttawit, et al.
Published: (2016)

Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus
by: Rishishwar, Lavanya, et al.
Published: (2016)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
by: Perazzi, Beatriz, et al.
Published: (2011)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
by: Perazzi, Beatriz, et al.
Published: (2011)

Decreased Vancomycin MICs among Methicillin-Resistant Staphylococcus aureus Clinical Isolates at a Chinese Tertiary Hospital over a 12-year Period
by: Lu, Chaohui, et al.
Published: (2016)

Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization1
by: Furuno, Jon P., et al.
Published: (2005)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
by: Ye Tian, et al.
Published: (2018-01-01)

Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
by: Karau, Melissa J, et al.
Published: (2013)

Vancomycin Ophthalmic Ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series
by: Sotozono, Chie, et al.
Published: (2013)

Staphylococcus aureus Bacteremia, Europe
by: Tiemersma, Edine W., et al.
Published: (2005)

Staphylococcus aureus Bacteremia, Australia
by: Collignon, Peter, et al.
Published: (2005)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
by: Kaur, Rajneet, et al.
Published: (2012)

Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia
by: Lee, Hao-Yuan, et al.
Published: (2015)

Long Term Molecular Epidemiology of Methicillin-Susceptible Staphylococcus aureus Bacteremia Isolates in Sweden
by: Rasmussen, Gunlög, et al.
Published: (2014)